The PRACS Institute facility in St. Louis specializes in research designed to obtain FDA approval of generic drugs by comparing them to name brand drugs. We perform metabolism studies to ensure that the generic drug and the marketed drug are similarly absorbed into the blood stream. We have been dedicated to this bioequivalence testing for 25 years. We also conduct research involving people with a wide variety of medical conditions. We have a record of 99% on-time study start-up. Our medical and clinical experts conduct studies across a wide range of indications with healthy participants, hard-to-find patients and special populations. Studies that involve study design, protocol development, data management, PK/PD modeling and simulation, and biostatistics. Quality of our services and our dedication to our partners comes from a company-wide focus on integrity, ethics, and teamwork.